Doctors Outraged: Kourtney Kardashian's 'Ozempic' & Cellulite Pills Slammed As Dangerous Fad
Kourtney Kardashian's supplement brand, Lemme, is under fire for launching an “Ozempic-style” weight-loss pill and other controversial products. Critics, including medical experts, accuse the brand of misleading marketing and exploiting body image insecurities for profit, raising concerns about the lack of scientific backing and FDA approval for these supplements.
Kourtney Kardashian Barker's supplement brand, Lemme, has faced significant scrutiny following the launch of several products, most notably an “Ozempic-style” weight-loss supplement named GLP-1 Daily. The Kar-Jenner sisters have long been associated with claims of using Ozempic for weight loss, a drug originally developed for diabetes but widely used as a weight-loss aid. Kourtney's new supplement, launched last week, capitalizes on this hype by directly referencing the GLP-1 hormone, which is mimicked by the synthetic ingredient in Ozempic to slow digestion and reduce hunger.
Lemme's GLP-1 Daily is marketed to “reduce body weight, visceral fat, and hip and waist circumference.” While the brand claims it naturally increases GLP-1 levels using lemon and saffron extracts, it explicitly states it does not contain the key ingredients found in actual Ozempic. Despite this, Kourtney promoted a WWD article discussing her desire to be “in on the Ozempic boom,” and brand emails described the product as “a GLP-1 solution without the side effects” of the injectable drug.
The product, priced at an eye-watering £69 for a one-time purchase or £55.23 for a monthly subscription, has drawn sharp criticism from fans and medical professionals alike. Many fans, noting Kourtney's past advocacy for body positivity, accused her of